Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 24% ± 9% | |
astrocyte | 10 studies | 29% ± 13% | |
oligodendrocyte | 7 studies | 29% ± 7% | |
glutamatergic neuron | 6 studies | 46% ± 24% | |
fibroblast | 6 studies | 22% ± 6% | |
GABAergic neuron | 6 studies | 40% ± 20% | |
Mueller cell | 5 studies | 23% ± 6% | |
oligodendrocyte precursor cell | 5 studies | 33% ± 12% | |
macrophage | 5 studies | 18% ± 3% | |
retinal bipolar neuron | 4 studies | 24% ± 3% | |
amacrine cell | 4 studies | 20% ± 5% | |
retina horizontal cell | 4 studies | 23% ± 3% | |
retinal cone cell | 4 studies | 20% ± 2% | |
retinal rod cell | 4 studies | 19% ± 3% | |
basal cell | 4 studies | 27% ± 14% | |
interneuron | 4 studies | 40% ± 21% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 2% | |
neuron | 3 studies | 28% ± 12% | |
retinal ganglion cell | 3 studies | 40% ± 14% | |
epithelial cell | 3 studies | 49% ± 17% | |
retinal pigment epithelial cell | 3 studies | 27% ± 3% | |
rod bipolar cell | 3 studies | 35% ± 0% | |
microglial cell | 3 studies | 26% ± 3% | |
pancreatic A cell | 3 studies | 25% ± 2% | |
pericyte | 3 studies | 23% ± 6% | |
adipocyte | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3851.79 | 180 / 180 | 100% | 27.59 | 429 / 430 |
brain | 100% | 3971.05 | 2639 / 2642 | 100% | 39.90 | 702 / 705 |
thymus | 100% | 4289.92 | 651 / 653 | 99% | 57.47 | 600 / 605 |
pancreas | 99% | 1510.59 | 324 / 328 | 99% | 24.09 | 177 / 178 |
prostate | 98% | 2905.68 | 241 / 245 | 100% | 31.04 | 500 / 502 |
breast | 99% | 3776.47 | 455 / 459 | 99% | 36.24 | 1105 / 1118 |
bladder | 100% | 2800.95 | 21 / 21 | 98% | 23.67 | 492 / 504 |
lung | 98% | 2633.13 | 569 / 578 | 99% | 28.69 | 1144 / 1155 |
esophagus | 98% | 2745.29 | 1421 / 1445 | 99% | 32.57 | 181 / 183 |
adrenal gland | 100% | 2866.08 | 257 / 258 | 97% | 40.62 | 224 / 230 |
uterus | 100% | 3967.22 | 170 / 170 | 95% | 25.52 | 435 / 459 |
stomach | 99% | 2069.19 | 355 / 359 | 96% | 22.90 | 274 / 286 |
intestine | 99% | 2943.12 | 958 / 966 | 94% | 19.77 | 498 / 527 |
kidney | 98% | 1915.16 | 87 / 89 | 94% | 24.02 | 845 / 901 |
skin | 100% | 3248.57 | 1803 / 1809 | 88% | 22.54 | 413 / 472 |
liver | 94% | 1689.59 | 212 / 226 | 91% | 16.04 | 370 / 406 |
spleen | 100% | 2051.30 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 4305.40 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3142.46 | 1317 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 3665.84 | 1186 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 40.31 | 44 / 45 |
heart | 92% | 1858.54 | 796 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 7.82 | 20 / 29 |
eye | 0% | 0 | 0 / 0 | 63% | 9.45 | 50 / 80 |
peripheral blood | 36% | 387.89 | 334 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_2001014 | Biological process | regulation of skeletal muscle cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0048512 | Biological process | circadian behavior |
GO_0055088 | Biological process | lipid homeostasis |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR1D2 |
Protein name | Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R) NR1D2 protein (Nuclear receptor subfamily 1 group D member 2) Nuclear receptor subfamily 1, group D, member 2 Nuclear receptor Rev-ErbA beta variant 2 (Nuclear receptor subfamily 1, group D, member 2, isoform CRA_b) (cDNA FLJ51368, highly similar to Orphan nuclear receptor NR1D2) Nuclear receptor Rev-ErbA beta variant 1 NR1D2 protein |
Synonyms | hCG_1778084 |
Description | FUNCTION: Transcriptional repressor which coordinates circadian rhythm and metabolic pathways in a heme-dependent manner. Integral component of the complex transcription machinery that governs circadian rhythmicity and forms a critical negative limb of the circadian clock by directly repressing the expression of core clock components BMAL1 and CLOCK. Also regulates genes involved in metabolic functions, including lipid metabolism and the inflammatory response. Acts as a receptor for heme which stimulates its interaction with the NCOR1/HDAC3 corepressor complex, enhancing transcriptional repression. Recognizes two classes of DNA response elements within the promoter of its target genes and can bind to DNA as either monomers or homodimers, depending on the nature of the response element. Binds as a monomer to a response element composed of the consensus half-site motif 5'-[A/G]GGTCA-3' preceded by an A/T-rich 5' sequence (RevRE), or as a homodimer to a direct repeat of the core motif spaced by two nuclegotides (RevDR-2). Acts as a potent competitive repressor of ROR alpha (RORA) function and also negatively regulates the expression of NR1D1. Regulates lipid and energy homeostasis in the skeletal muscle via repression of genes involved in lipid metabolism and myogenesis including: CD36, FABP3, FABP4, UCP3, SCD1 and MSTN. Regulates hepatic lipid metabolism via the repression of APOC3. Represses gene expression at a distance in macrophages by inhibiting the transcription of enhancer-derived RNAs (eRNAs). In addition to its activity as a repressor, can also act as a transcriptional activator. Acts as a transcriptional activator of the sterol regulatory element-binding protein 1 (SREBF1) and the inflammatory mediator interleukin-6 (IL6) in the skeletal muscle (By similarity). Plays a role in the regulation of circadian sleep/wake cycle; essential for maintaining wakefulness during the dark phase or active period (By similarity). Key regulator of skeletal muscle mitochondrial function; negatively regulates the skeletal muscle expression of core clock genes and genes involved in mitochondrial biogenesis, fatty acid beta-oxidation and lipid metabolism (By similarity). May play a role in the circadian control of neutrophilic inflammation in the lung (By similarity). . |
Accessions | ENST00000312521.9 B6ZGS3 Q6I9S1 Q6NSM0 Q96B66 B4DXD3 Q14995 F1D8P2 ENST00000383773.8 |